Besides, though MMP-9, EGFR, GST-π, and TOPO II all play crucial roles in the progression, invasion, migration and dissemination of gliomas, their expression levels do not differed among divergent recurrence groups, indicating that the recurrence pattern may not be determined by these molecules. The gene discussed is EGFR; the disease is central nervous system cancer.